Nureca IPO Listing: In talk with Anil Singhvi, Founder & CEO Aryan Goyal reveals company's outlook
Nureca IPO Listing: Nureca issue registered a bumper listing today at Rs 635 on the BSE (Bombay Stock Exchange).
Nureca IPO Listing: Nureca issue registered a bumper listing today at Rs 635 on the BSE (Bombay Stock Exchange). Notably, Zee Business Managing Editor Anil Singhvi has been batting in favour of stock investors to go for Nureca IPO (both for short-term and long-term). After the robust Nureca IPO performance on the BSE and NSE, Singhvi talked to Founder and CEO of the company Aryan Goyal and unveiled the money making strategy in regard to Nureca share price.
Speaking on the strategy in regard to Nureca share price, Anil Singhvi said, "I have been maintaining that one can bid for Nureca IPO for both short-term and very long-term. The reason for this was the bumper listing gains that were expected from Nureca IPO listing, which has come true today. But those who want to maximise their gains, can hold this for more than one year as the business model of the company is still promising."
On the business model and how the company is planning to beat the hurdles coming in its way, Aryan Goyal told Anil Singhvi, "We have contract manufacturing model of business. So, it may happen that our suppliers may think of selling their products on their own. In that case, we are also planning to foray into the manufacturing zone as we already have a small manufacturing unit though it's very small. However, to start with, it's enough to begin manufacturing on our own."
WATCH | Click on Zee Business Live TV Streaming Below:
Anil Singhvi said that COVID-19 has pushed Nureca business in the last one year but after pandemic subsides, the company will have a huge challenge to maintain its business at the same levels.
To this, Aryan Goyal said that Nureca has been introducing new products and technology that have been keeping its business volume at the same levels. Last year it was Oximeter and Thermometer while next year it can be any other product or technology.
WATCH | Full coverage in Zee Business video below:
न्यूरेका की 56% प्रीमियम पर शानदार लिस्टिंग... #NewsParViews में कंपनी के फाउंडर & CEO आर्यन गोयल ने दिया अच्छी ग्रोथ का भरोसा#NewsParViews #Nureca #IPO @AnilSinghvi_ pic.twitter.com/G8FvE8ZNOL
— Zee Business (@ZeeBusiness) February 25, 2021
"On Year on Year (YoY) basis, our business volume has been growing at 11 per cent and our market share is near 30 per cent of the net Indian market, which we expect to continue in years to come as well," said Aryan Goyal.
So, on the expectations that its business volume will continue to grow stronger, Anil Singhvi advised investors to hold on for the long-term as Nureca share price outlook looks promising.
04:29 PM IST